Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
6.51
-0.21 (-3.12%)
At close: Dec 5, 2025, 4:00 PM EST
6.64
+0.13 (2.00%)
After-hours: Dec 5, 2025, 7:17 PM EST
Xeris Biopharma Holdings Employees
Xeris Biopharma Holdings had 394 employees as of December 31, 2024. The number of employees increased by 17 or 4.51% compared to the previous year.
Employees
394
Change (1Y)
17
Growth (1Y)
4.51%
Revenue / Employee
$675,475
Profits / Employee
-$39,695
Market Cap
1.08B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
XERS News
- 4 days ago - Xeris Announces Notice of Allowance from U.S. Patent and Trademark Office for XP-8121 Patent Application - Business Wire
- 4 weeks ago - Xeris Biopharma Holdings, Inc. (XERS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Xeris Biopharma Posts Record Financial Results for the Third Quarter 2025 - Business Wire
- 6 weeks ago - Xeris Biopharma to Report Third Quarter 2025 Financial Results on November 6, 2025 - Business Wire
- 2 months ago - Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 3 months ago - Xeris In Recorlev-Fuelled Growth: Why I Choose To Buy - Seeking Alpha
- 3 months ago - Xeris Announces Orange Book Listing of U.S. Patent for Recorlev® - Business Wire
- 4 months ago - Xeris Biopharma Holdings, Inc. (XERS) Q2 2025 Earnings Call Transcript - Seeking Alpha